A recent study reveals a link between belly fat and psoriasis, especially in women. Researchers analyzed data from UK Biobank ...

People with psoriasis share their experiences and how they learned to manage issues with body image, self ... long sleeves and full-length slacks or pants became a wardrobe staple despite the ...

The autoimmune disease causes raised, scaly patches of skin. As a child, it left the football star embarrassed to remove his ...

Psoriasis affects more than your skin. Here’s how inflammation throughout your body can contribute to a host of health complications. Psoriasis: How It Affects Your Gut, Heart, and More ...

Roflumilast foam, 0.3% (Zoryve) used once-daily significantly improved itch and other symptoms of plaque psoriasis of the scalp and body, the phase III ARRECTOR trial showed. At week 8 ...

Michelle Lee had an itchy skin rash from plaque psoriasis for months, ... Then, overnight, those three dots became hundreds of dots all over my body like a red, angry, full-body rash.

A total of 432 patients (56.3% women) aged 12 and older with psoriasis on the scalp and body were randomly assigned to two groups, one of which used roflumilast foam 0.3% once a day for eight ...

Fat around the abdomen is more strongly linked to psoriasis risk that total body fat, particularly in women. “Our research shows that where fat is stored in the body matters when it comes to ...

Full-body sessions are a better bet for beginners and those with a smaller workout window. For gym veterans with specific muscle-building goals, the road to gains may be paved with split sessions.

Approximately 40% of the 9 million individuals in the United States with plaque psoriasis experience involvement of the scalpOnce-daily ZORYVE foa ...

Psoriasis Scalp Severity Index 90 (PSSI 90) response rates were 60.7% and 4.9% at week 16 in the tildrakizumab and placebo groups, rising to 65.2% and 57.3%, respectively, at week 52.

Read full-text medical journal articles from Medscape's ... Body Psoriasis The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults ...